These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 32780290)

  • 1. The microbial coinfection in COVID-19.
    Chen X; Liao B; Cheng L; Peng X; Xu X; Li Y; Hu T; Li J; Zhou X; Ren B
    Appl Microbiol Biotechnol; 2020 Sep; 104(18):7777-7785. PubMed ID: 32780290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Ahlawat S; Asha ; Sharma KK
    Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
    Schönrich G; Raftery MJ; Samstag Y
    Adv Biol Regul; 2020 Aug; 77():100741. PubMed ID: 32773102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19: Time for a paradigm change.
    Buonaguro FM; Ascierto PA; Morse GD; Buonaguro L; Puzanov I; Tornesello ML; Bréchot C; Gallo RC
    Rev Med Virol; 2020 Sep; 30(5):e2134. PubMed ID: 32618072
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
    Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
    Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options.
    Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Roudbary M; Dos Santos ALS
    Curr Top Med Chem; 2020; 20(22):1951-1957. PubMed ID: 33040728
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-infections in people with COVID-19: a systematic review and meta-analysis.
    Lansbury L; Lim B; Baskaran V; Lim WS
    J Infect; 2020 Aug; 81(2):266-275. PubMed ID: 32473235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
    Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
    Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
    Keam S; Megawati D; Patel SK; Tiwari R; Dhama K; Harapan H
    Rev Med Virol; 2020 Sep; 30(5):e2123. PubMed ID: 32648313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 13. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells.
    Ratajczak MZ; Kucia M
    Leukemia; 2020 Jul; 34(7):1726-1729. PubMed ID: 32483300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report.
    Baumann T; Delgado J; Montserrat E
    Leukemia; 2020 Jul; 34(7):1954-1956. PubMed ID: 32433507
    [No Abstract]   [Full Text] [Related]  

  • 17. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.
    Prezioso C; Marcocci ME; Palamara AT; De Chiara G; Pietropaolo V
    J Neurovirol; 2020 Jun; 26(3):311-323. PubMed ID: 32548750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
    Chrousos GP; Meduri GU
    Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.